Portfolio (Quarterly)
Guide ↗
Defilade Capital Management, L.P.
· CIK 0002088557| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | LNTH | LANTHEUS HLDGS INC | Healthcare | 132,662.0 | $14.7M | 1.97% | NEW | — | $110.94 | -9.7% |
| 22 | OCUL | OCULAR THERAPEUTIX INC | Healthcare | 1,490,286.0 | $14.6M | 1.96% | NEW | — | $9.82 | +16.5% |
| 23 | ELDN | ELEDON PHARMACEUTICALS INC | Healthcare | 3,525,338.0 | $13.9M | 1.86% | NEW | — | $3.94 | -12.6% |
| 24 | TYRA | TYRA BIOSCIENCES INC | Healthcare | 376,870.0 | $12.0M | 1.61% | NEW | — | $31.94 | -20.0% |
| 25 | OLMA | OLEMA PHARMACEUTICALS INC | Healthcare | 924,758.0 | $11.6M | 1.55% | NEW | — | $12.51 | -13.5% |
| 26 | ORIC | ORIC PHARMACEUTICALS INC | Healthcare | 1,047,690.0 | $11.3M | 1.52% | NEW | — | $10.83 | +31.0% |
| 27 | LRMR | LARIMAR THERAPEUTICS INC | Healthcare | 3,670,135.0 | $11.2M | 1.50% | NEW | — | $3.05 | +33.1% |
| 28 | — | GLOBUS MED INC | — | 139,637.0 | $11.0M | 1.48% | NEW | — | $79.01 | — |
| 29 | ENOV | ENOVIS CORPORATION | Industrials | 531,945.0 | $11.0M | 1.47% | NEW | — | $20.70 | +28.8% |
| 30 | EVMN | EVOMMUNE INC | Healthcare | 793,145.0 | $10.5M | 1.41% | NEW | — | $13.29 | +0.6% |
| 31 | TFX | TELEFLEX INCORPORATED | Healthcare | 80,118.0 | $10.2M | 1.36% | NEW | — | $126.76 | +7.7% |
| 32 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 391,866.0 | $10.1M | 1.35% | NEW | — | $25.72 | -3.1% |
| 33 | GKOS | GLAUKOS CORP | Healthcare | 66,519.0 | $9.3M | 1.25% | NEW | — | $139.76 | +35.7% |
| 34 | STAA | STAAR SURGICAL CO | Healthcare | 322,126.0 | $9.2M | 1.24% | NEW | — | $28.69 | -16.7% |
| 35 | PACS | PACS GROUP INC | Financial Services | 215,675.0 | $9.2M | 1.23% | NEW | — | $42.64 | +3.0% |
| 36 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 239,440.0 | $9.0M | 1.20% | NEW | — | $37.42 | +126.3% |
| 37 | LIVN | LIVANOVA PLC | Healthcare | 107,373.0 | $8.8M | 1.18% | NEW | — | $82.23 | -4.1% |
| 38 | BDTX | BLACK DIAMOND THERAPEUTICS I | Healthcare | 1,674,999.0 | $3.1M | 0.41% | NEW | — | $1.85 | +14.3% |
| 39 | MREO | MEREO BIOPHARMA GROUP PLC | Healthcare | 7,558,756.0 | $2.4M | 0.32% | NEW | — | $0.32 | -5.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
97.2%
Industrials
1.5%
Financial Services
1.3%